PHSSR Policy Roadmaps for Acting Early on NCDs Synthesis Report 2025
Page 70 of 124 · WEF_PHSSR_Policy_Roadmaps_for_Acting_Early_on_NCDs_Synthesis_Report_2025.pdf
67 Acting early on NCDs
The Partnership for Health System Sustainability and Resiliencedevelopment necessarily relied on alternative data sources of questionable quality and
completeness. France’s cancer registries through the Francim network provide detailed insights
whilst covering approximately one-quarter of the population, acknowledging incomplete national
representation but providing high-quality data for covered areas.
Spain has developed multiple disease-specific registries, including a National Registry of Type 1
Diabetes in 2022, though these currently operate without interoperability, limiting analysis of
multimorbidity patterns. Most registries focus on hospitalised patients, offering important burden
data though missing earlier disease stages relevant for prevention planning. The fragmentation of
registry systems reflects broader governance challenges in creating unified approaches across
autonomous regions.
National surveillance systems provide essential population health monitoring with varying
sophistication. Canada’s federal surveillance system successfully aggregates data from all
provinces and territories to track 20 chronic diseases, demonstrating that comprehensive coverage
across jurisdictions is achievable despite federal structures (Government of Canada, 2024a). Spain
conducts regular surveys meeting WHO standards for NCD risk factors, documenting regional
variations in service access. Poland’s weather alert systems identify climate impacts on health but
lack protocols for adjusting clinical management during extreme events, illustrating the gap between
data collection and operational response.
Translating data into policy
The mechanisms for translating surveillance findings and data into policy action vary considerably
across countries, with formal response pathways appearing critical for effective evidence use.
Canada’s comprehensive cancer surveillance has informed the Canadian Strategy for Cancer
Control (2019–2029), a national framework with defined priority areas, accountability mechanisms,
and ongoing monitoring led by the Canadian Partnership Against Cancer (CPAC) (Canadian
Partnership Against Cancer, 2019), demonstrating how surveillance can support comprehensive
planning with defined accountability mechanisms. However, beyond cancer and more recently
diabetes, most major NCDs still lack equivalent national frameworks, suggesting that the availability
of surveillance data alone does not guarantee policy development (Public Health Agency of Canada,
2022; HeartLife Foundation, 2024b). Similarly, the relatively limited research use of Japan’s
comprehensive National Database of Health Insurance Claims and Specific Health Checkups, which
had only 50 applications between 2018–2023, suggests that access barriers and data gaps may
constrain policy utility even in sophisticated systems (MHLW, 2024g).
Countries generally lack formal requirements for policies to reference national data sources or
respond to surveillance findings. Without mandatory links between evidence and policy, decision-
making may reflect political priorities or stakeholder influence rather than epidemiological need. This
creates a vicious cycle where prevention remains underfunded because its benefits cannot be
demonstrated, whilst demonstration requires investments in evaluation infrastructure that seem
unjustifiable without proven benefits.
Stakeholder engagement and inclusivity
Whilst robust data systems and evidence mechanisms provide the technical foundation for
governance, the legitimacy and effectiveness of NCD policies ultimately depend on meaningful
engagement with those affected by and implementing these policies.
Japan’s expert evaluation committees provide a model for systematic multi-stakeholder
engagement, with formal representation protocols ensuring that medical expertise, patient
experience, and implementation capacity all contribute to decision-making processes (MHLW,
2024l). These committees include mandatory representation from patient organisations, creating
Ask AI what this page says about a topic: